OneMedNet Corp ONMD
Nasdaq · stock · Services-Commercial Physical & Biological Research · website · IPO 2021-05-07
OneMedNet Corp statistics & valuation
Market cap$35.9M
P / S26.4×
Net margin-206.1%
FCF margin-553.1%
Net cash$365,000
Enterprise value USD$35.6M
Earnings yield EBIT/EV-27.2%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | -37.0% | -43.7% | -12.6% | -31.3% |
| Operating margin | -711.3% | -1493.8% | -671.2% | -991.2% |
| Net margin | -206.1% | -1575.3% | -3308.5% | -540.4% |
| FCF margin | -553.1% | -1089.1% | -473.6% | 7563.0% |
| Return on assets | -130.2% | -271.8% | -7280.2% | -20.5% |
| Return on equity | 94.5% | 63.5% | 251.3% | 23.6% |
| Debt / equity | -0.07× | -0.15× | -0.03× | — |
| Current ratio | 0.43 | 0.19 | 0.03 | 2.58 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.